aluates Reports

$ 0.0

Automative

Global Cold Sore Antiviral Drug Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-36H14013

Global Cold Sore Antiviral Drug Market Research Report 2023

BUY CHAPTERS

Global Cold Sore Antiviral Drug Market Research Report 2024

Code: QYRE-Auto-36H14013

Report

August 2024

Pages:104

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Cold Sore Antiviral Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Cold Sore Antiviral Drug Market

The global Cold Sore Antiviral Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Cold Sore Antiviral Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cold Sore Antiviral Drug.

Report Scope

The Cold Sore Antiviral Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cold Sore Antiviral Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cold Sore Antiviral Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cold Sore Antiviral Drug Market Report

Report Metric	Details
Report Name	Cold Sore Antiviral Drug Market
CAGR	5%
Segment by Type	Smear Oral Others
Segment by Application	Child Aldult
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex, Aurobindo Pharma USA, Inc., Cipla, Glenmark Pharmaceuticals, Inc., Hikma Pharmaceuticals, HRA Pharma, Hetero Healthcare Ltd, Jubilant Cadista, Merix Pharmaceutical Corp, Sun Pharmaceutical Industries Ltd., Viatris, Wockhardt, Zydus Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cold Sore Antiviral Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cold Sore Antiviral Drug Market report?

Ans: The main players in the Cold Sore Antiviral Drug Market are GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex, Aurobindo Pharma USA, Inc., Cipla, Glenmark Pharmaceuticals, Inc., Hikma Pharmaceuticals, HRA Pharma, Hetero Healthcare Ltd, Jubilant Cadista, Merix Pharmaceutical Corp, Sun Pharmaceutical Industries Ltd., Viatris, Wockhardt, Zydus Pharmaceuticals

What are the Application segmentation covered in the Cold Sore Antiviral Drug Market report?

Ans: The Applications covered in the Cold Sore Antiviral Drug Market report are Child, Aldult

What are the Type segmentation covered in the Cold Sore Antiviral Drug Market report?

Ans: The Types covered in the Cold Sore Antiviral Drug Market report are Smear, Oral, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cold Sore Antiviral Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Smear

1.2.3 Oral

1.2.4 Others

1.3 Market by Application

1.3.1 Global Cold Sore Antiviral Drug Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Child

1.3.3 Aldult

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cold Sore Antiviral Drug Market Perspective (2019-2030)

2.2 Cold Sore Antiviral Drug Growth Trends by Region

2.2.1 Global Cold Sore Antiviral Drug Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cold Sore Antiviral Drug Historic Market Size by Region (2019-2024)

2.2.3 Cold Sore Antiviral Drug Forecasted Market Size by Region (2025-2030)

2.3 Cold Sore Antiviral Drug Market Dynamics

2.3.1 Cold Sore Antiviral Drug Industry Trends

2.3.2 Cold Sore Antiviral Drug Market Drivers

2.3.3 Cold Sore Antiviral Drug Market Challenges

2.3.4 Cold Sore Antiviral Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cold Sore Antiviral Drug Players by Revenue

3.1.1 Global Top Cold Sore Antiviral Drug Players by Revenue (2019-2024)

3.1.2 Global Cold Sore Antiviral Drug Revenue Market Share by Players (2019-2024)

3.2 Global Cold Sore Antiviral Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cold Sore Antiviral Drug Revenue

3.4 Global Cold Sore Antiviral Drug Market Concentration Ratio

3.4.1 Global Cold Sore Antiviral Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cold Sore Antiviral Drug Revenue in 2023

3.5 Cold Sore Antiviral Drug Key Players Head office and Area Served

3.6 Key Players Cold Sore Antiviral Drug Product Solution and Service

3.7 Date of Enter into Cold Sore Antiviral Drug Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cold Sore Antiviral Drug Breakdown Data by Type

4.1 Global Cold Sore Antiviral Drug Historic Market Size by Type (2019-2024)

4.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2025-2030)

5 Cold Sore Antiviral Drug Breakdown Data by Application

5.1 Global Cold Sore Antiviral Drug Historic Market Size by Application (2019-2024)

5.2 Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cold Sore Antiviral Drug Market Size (2019-2030)

6.2 North America Cold Sore Antiviral Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cold Sore Antiviral Drug Market Size by Country (2019-2024)

6.4 North America Cold Sore Antiviral Drug Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cold Sore Antiviral Drug Market Size (2019-2030)

7.2 Europe Cold Sore Antiviral Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cold Sore Antiviral Drug Market Size by Country (2019-2024)

7.4 Europe Cold Sore Antiviral Drug Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cold Sore Antiviral Drug Market Size (2019-2030)

8.2 Asia-Pacific Cold Sore Antiviral Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2019-2024)

8.4 Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cold Sore Antiviral Drug Market Size (2019-2030)

9.2 Latin America Cold Sore Antiviral Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cold Sore Antiviral Drug Market Size by Country (2019-2024)

9.4 Latin America Cold Sore Antiviral Drug Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cold Sore Antiviral Drug Market Size (2019-2030)

10.2 Middle East & Africa Cold Sore Antiviral Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2019-2024)

10.4 Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Introduction

11.1.4 GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Ortho Dermatologics

11.2.1 Ortho Dermatologics Company Detail

11.2.2 Ortho Dermatologics Business Overview

11.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Introduction

11.2.4 Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.2.5 Ortho Dermatologics Recent Development

11.3 Foundation Consumer Healthcare

11.3.1 Foundation Consumer Healthcare Company Detail

11.3.2 Foundation Consumer Healthcare Business Overview

11.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Introduction

11.3.4 Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.3.5 Foundation Consumer Healthcare Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Cold Sore Antiviral Drug Introduction

11.4.4 Novartis Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.4.5 Novartis Recent Development

11.5 Teva Pharmaceuticals

11.5.1 Teva Pharmaceuticals Company Detail

11.5.2 Teva Pharmaceuticals Business Overview

11.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Introduction

11.5.4 Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.5.5 Teva Pharmaceuticals Recent Development

11.6 Amneal Pharmaceuticals LLC

11.6.1 Amneal Pharmaceuticals LLC Company Detail

11.6.2 Amneal Pharmaceuticals LLC Business Overview

11.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Introduction

11.6.4 Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.6.5 Amneal Pharmaceuticals LLC Recent Development

11.7 AiCuris

11.7.1 AiCuris Company Detail

11.7.2 AiCuris Business Overview

11.7.3 AiCuris Cold Sore Antiviral Drug Introduction

11.7.4 AiCuris Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.7.5 AiCuris Recent Development

11.8 Apotex

11.8.1 Apotex Company Detail

11.8.2 Apotex Business Overview

11.8.3 Apotex Cold Sore Antiviral Drug Introduction

11.8.4 Apotex Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.8.5 Apotex Recent Development

11.9 Aurobindo Pharma USA, Inc.

11.9.1 Aurobindo Pharma USA, Inc. Company Detail

11.9.2 Aurobindo Pharma USA, Inc. Business Overview

11.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Introduction

11.9.4 Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.9.5 Aurobindo Pharma USA, Inc. Recent Development

11.10 Cipla

11.10.1 Cipla Company Detail

11.10.2 Cipla Business Overview

11.10.3 Cipla Cold Sore Antiviral Drug Introduction

11.10.4 Cipla Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.10.5 Cipla Recent Development

11.11 Glenmark Pharmaceuticals, Inc.

11.11.1 Glenmark Pharmaceuticals, Inc. Company Detail

11.11.2 Glenmark Pharmaceuticals, Inc. Business Overview

11.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Introduction

11.11.4 Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.11.5 Glenmark Pharmaceuticals, Inc. Recent Development

11.12 Hikma Pharmaceuticals

11.12.1 Hikma Pharmaceuticals Company Detail

11.12.2 Hikma Pharmaceuticals Business Overview

11.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Introduction

11.12.4 Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.12.5 Hikma Pharmaceuticals Recent Development

11.13 HRA Pharma

11.13.1 HRA Pharma Company Detail

11.13.2 HRA Pharma Business Overview

11.13.3 HRA Pharma Cold Sore Antiviral Drug Introduction

11.13.4 HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.13.5 HRA Pharma Recent Development

11.14 Hetero Healthcare Ltd

11.14.1 Hetero Healthcare Ltd Company Detail

11.14.2 Hetero Healthcare Ltd Business Overview

11.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Introduction

11.14.4 Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.14.5 Hetero Healthcare Ltd Recent Development

11.15 Jubilant Cadista

11.15.1 Jubilant Cadista Company Detail

11.15.2 Jubilant Cadista Business Overview

11.15.3 Jubilant Cadista Cold Sore Antiviral Drug Introduction

11.15.4 Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.15.5 Jubilant Cadista Recent Development

11.16 Merix Pharmaceutical Corp

11.16.1 Merix Pharmaceutical Corp Company Detail

11.16.2 Merix Pharmaceutical Corp Business Overview

11.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Introduction

11.16.4 Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.16.5 Merix Pharmaceutical Corp Recent Development

11.17 Sun Pharmaceutical Industries Ltd.

11.17.1 Sun Pharmaceutical Industries Ltd. Company Detail

11.17.2 Sun Pharmaceutical Industries Ltd. Business Overview

11.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Introduction

11.17.4 Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.17.5 Sun Pharmaceutical Industries Ltd. Recent Development

11.18 Viatris

11.18.1 Viatris Company Detail

11.18.2 Viatris Business Overview

11.18.3 Viatris Cold Sore Antiviral Drug Introduction

11.18.4 Viatris Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.18.5 Viatris Recent Development

11.19 Wockhardt

11.19.1 Wockhardt Company Detail

11.19.2 Wockhardt Business Overview

11.19.3 Wockhardt Cold Sore Antiviral Drug Introduction

11.19.4 Wockhardt Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.19.5 Wockhardt Recent Development

11.20 Zydus Pharmaceuticals

11.20.1 Zydus Pharmaceuticals Company Detail

11.20.2 Zydus Pharmaceuticals Business Overview

11.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Introduction

11.20.4 Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2019-2024)

11.20.5 Zydus Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Cold Sore Antiviral Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Smear

Table 3. Key Players of Oral

Table 4. Key Players of Others

Table 5. Global Cold Sore Antiviral Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cold Sore Antiviral Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cold Sore Antiviral Drug Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cold Sore Antiviral Drug Market Share by Region (2019-2024)

Table 9. Global Cold Sore Antiviral Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cold Sore Antiviral Drug Market Share by Region (2025-2030)

Table 11. Cold Sore Antiviral Drug Market Trends

Table 12. Cold Sore Antiviral Drug Market Drivers

Table 13. Cold Sore Antiviral Drug Market Challenges

Table 14. Cold Sore Antiviral Drug Market Restraints

Table 15. Global Cold Sore Antiviral Drug Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cold Sore Antiviral Drug Market Share by Players (2019-2024)

Table 17. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2023)

Table 18. Ranking of Global Top Cold Sore Antiviral Drug Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cold Sore Antiviral Drug Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cold Sore Antiviral Drug Product Solution and Service

Table 22. Date of Enter into Cold Sore Antiviral Drug Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cold Sore Antiviral Drug Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2019-2024)

Table 26. Global Cold Sore Antiviral Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cold Sore Antiviral Drug Revenue Market Share by Type (2025-2030)

Table 28. Global Cold Sore Antiviral Drug Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2019-2024)

Table 30. Global Cold Sore Antiviral Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cold Sore Antiviral Drug Revenue Market Share by Application (2025-2030)

Table 32. North America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cold Sore Antiviral Drug Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cold Sore Antiviral Drug Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cold Sore Antiviral Drug Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cold Sore Antiviral Drug Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cold Sore Antiviral Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cold Sore Antiviral Drug Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cold Sore Antiviral Drug Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cold Sore Antiviral Drug Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cold Sore Antiviral Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cold Sore Antiviral Drug Market Size by Country (2025-2030) & (US$ Million)

Table 47. GlaxoSmithKline Company Detail

Table 48. GlaxoSmithKline Business Overview

Table 49. GlaxoSmithKline Cold Sore Antiviral Drug Product

Table 50. GlaxoSmithKline Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 51. GlaxoSmithKline Recent Development

Table 52. Ortho Dermatologics Company Detail

Table 53. Ortho Dermatologics Business Overview

Table 54. Ortho Dermatologics Cold Sore Antiviral Drug Product

Table 55. Ortho Dermatologics Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 56. Ortho Dermatologics Recent Development

Table 57. Foundation Consumer Healthcare Company Detail

Table 58. Foundation Consumer Healthcare Business Overview

Table 59. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product

Table 60. Foundation Consumer Healthcare Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 61. Foundation Consumer Healthcare Recent Development

Table 62. Novartis Company Detail

Table 63. Novartis Business Overview

Table 64. Novartis Cold Sore Antiviral Drug Product

Table 65. Novartis Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 66. Novartis Recent Development

Table 67. Teva Pharmaceuticals Company Detail

Table 68. Teva Pharmaceuticals Business Overview

Table 69. Teva Pharmaceuticals Cold Sore Antiviral Drug Product

Table 70. Teva Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 71. Teva Pharmaceuticals Recent Development

Table 72. Amneal Pharmaceuticals LLC Company Detail

Table 73. Amneal Pharmaceuticals LLC Business Overview

Table 74. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product

Table 75. Amneal Pharmaceuticals LLC Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 76. Amneal Pharmaceuticals LLC Recent Development

Table 77. AiCuris Company Detail

Table 78. AiCuris Business Overview

Table 79. AiCuris Cold Sore Antiviral Drug Product

Table 80. AiCuris Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 81. AiCuris Recent Development

Table 82. Apotex Company Detail

Table 83. Apotex Business Overview

Table 84. Apotex Cold Sore Antiviral Drug Product

Table 85. Apotex Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 86. Apotex Recent Development

Table 87. Aurobindo Pharma USA, Inc. Company Detail

Table 88. Aurobindo Pharma USA, Inc. Business Overview

Table 89. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product

Table 90. Aurobindo Pharma USA, Inc. Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 91. Aurobindo Pharma USA, Inc. Recent Development

Table 92. Cipla Company Detail

Table 93. Cipla Business Overview

Table 94. Cipla Cold Sore Antiviral Drug Product

Table 95. Cipla Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 96. Cipla Recent Development

Table 97. Glenmark Pharmaceuticals, Inc. Company Detail

Table 98. Glenmark Pharmaceuticals, Inc. Business Overview

Table 99. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product

Table 100. Glenmark Pharmaceuticals, Inc. Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 101. Glenmark Pharmaceuticals, Inc. Recent Development

Table 102. Hikma Pharmaceuticals Company Detail

Table 103. Hikma Pharmaceuticals Business Overview

Table 104. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product

Table 105. Hikma Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 106. Hikma Pharmaceuticals Recent Development

Table 107. HRA Pharma Company Detail

Table 108. HRA Pharma Business Overview

Table 109. HRA Pharma Cold Sore Antiviral Drug Product

Table 110. HRA Pharma Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 111. HRA Pharma Recent Development

Table 112. Hetero Healthcare Ltd Company Detail

Table 113. Hetero Healthcare Ltd Business Overview

Table 114. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product

Table 115. Hetero Healthcare Ltd Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 116. Hetero Healthcare Ltd Recent Development

Table 117. Jubilant Cadista Company Detail

Table 118. Jubilant Cadista Business Overview

Table 119. Jubilant Cadista Cold Sore Antiviral Drug Product

Table 120. Jubilant Cadista Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 121. Jubilant Cadista Recent Development

Table 122. Merix Pharmaceutical Corp Company Detail

Table 123. Merix Pharmaceutical Corp Business Overview

Table 124. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product

Table 125. Merix Pharmaceutical Corp Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 126. Merix Pharmaceutical Corp Recent Development

Table 127. Sun Pharmaceutical Industries Ltd. Company Detail

Table 128. Sun Pharmaceutical Industries Ltd. Business Overview

Table 129. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product

Table 130. Sun Pharmaceutical Industries Ltd. Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 131. Sun Pharmaceutical Industries Ltd. Recent Development

Table 132. Viatris Company Detail

Table 133. Viatris Business Overview

Table 134. Viatris Cold Sore Antiviral Drug Product

Table 135. Viatris Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 136. Viatris Recent Development

Table 137. Wockhardt Company Detail

Table 138. Wockhardt Business Overview

Table 139. Wockhardt Cold Sore Antiviral Drug Product

Table 140. Wockhardt Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 141. Wockhardt Recent Development

Table 142. Zydus Pharmaceuticals Company Detail

Table 143. Zydus Pharmaceuticals Business Overview

Table 144. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product

Table 145. Zydus Pharmaceuticals Revenue in Cold Sore Antiviral Drug Business (2019-2024) & (US$ Million)

Table 146. Zydus Pharmaceuticals Recent Development

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cold Sore Antiviral Drug Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cold Sore Antiviral Drug Market Share by Type: 2023 VS 2030

Figure 3. Smear Features

Figure 4. Oral Features

Figure 5. Others Features

Figure 6. Global Cold Sore Antiviral Drug Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cold Sore Antiviral Drug Market Share by Application: 2023 VS 2030

Figure 8. Child Case Studies

Figure 9. Aldult Case Studies

Figure 10. Cold Sore Antiviral Drug Report Years Considered

Figure 11. Global Cold Sore Antiviral Drug Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Cold Sore Antiviral Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Cold Sore Antiviral Drug Market Share by Region: 2023 VS 2030

Figure 14. Global Cold Sore Antiviral Drug Market Share by Players in 2023

Figure 15. Global Top Cold Sore Antiviral Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cold Sore Antiviral Drug as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Cold Sore Antiviral Drug Revenue in 2023

Figure 17. North America Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Cold Sore Antiviral Drug Market Share by Country (2019-2030)

Figure 19. United States Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Cold Sore Antiviral Drug Market Share by Country (2019-2030)

Figure 23. Germany Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Cold Sore Antiviral Drug Market Share by Region (2019-2030)

Figure 31. China Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Cold Sore Antiviral Drug Market Share by Country (2019-2030)

Figure 39. Mexico Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Cold Sore Antiviral Drug Market Share by Country (2019-2030)

Figure 43. Turkey Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Cold Sore Antiviral Drug Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. GlaxoSmithKline Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 46. Ortho Dermatologics Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 47. Foundation Consumer Healthcare Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 48. Novartis Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 50. Amneal Pharmaceuticals LLC Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 51. AiCuris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 52. Apotex Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 53. Aurobindo Pharma USA, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 54. Cipla Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 55. Glenmark Pharmaceuticals, Inc. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 56. Hikma Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 57. HRA Pharma Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 58. Hetero Healthcare Ltd Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 59. Jubilant Cadista Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 60. Merix Pharmaceutical Corp Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 61. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 62. Viatris Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 63. Wockhardt Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 64. Zydus Pharmaceuticals Revenue Growth Rate in Cold Sore Antiviral Drug Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Cold Sore Antiviral Drug Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-36H14013

Global Cold Sore Antiviral Drug Market Research Report 2024

FEATURED COMPANIES

Cold Sore Antiviral Drug Market Size

Cold Sore Antiviral Drug Market

Report Scope

Scope of Cold Sore Antiviral Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Cold Sore Antiviral Drug Market report?

What are the Application segmentation covered in the Cold Sore Antiviral Drug Market report?

What are the Type segmentation covered in the Cold Sore Antiviral Drug Market report?

FEATURED COMPANIES